NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Sharma P, Boyers D, Boachie C, et al. Elucigene FH20 and LIPOchip for the Diagnosis of Familial Hypercholesterolaemia: A Systematic Review and Economic Evaluation. Southampton (UK): NIHR Journals Library; 2012 Mar. (Health Technology Assessment, No. 16.17.)

Cover of Elucigene FH20 and LIPOchip for the Diagnosis of Familial Hypercholesterolaemia: A Systematic Review and Economic Evaluation

Elucigene FH20 and LIPOchip for the Diagnosis of Familial Hypercholesterolaemia: A Systematic Review and Economic Evaluation.

Show details

Appendix 15Cost-effectiveness acceptability curves for each age subgroup

FIGURE 13. Cost-effectiveness acceptability curve: age 15 years, index case.

FIGURE 13Cost-effectiveness acceptability curve: age 15 years, index case

FIGURE 14. Cost-effectiveness acceptability curve: age 30 years, index case.

FIGURE 14Cost-effectiveness acceptability curve: age 30 years, index case

FIGURE 15. Cost-effectiveness acceptability curve: age 65 years, index case.

FIGURE 15Cost-effectiveness acceptability curve: age 65 years, index case

FIGURE 16. Cost-effectiveness acceptability curve: age 75 years, index case.

FIGURE 16Cost-effectiveness acceptability curve: age 75 years, index case

FIGURE 17. Cost-effectiveness acceptability curve: age 85 years, index case.

FIGURE 17Cost-effectiveness acceptability curve: age 85 years, index case

© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

Bookshelf ID: NBK97916

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (2.1M)

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...